Ariosa Diagnostics

Ariosa Diagnostics, Inc., maker of the Harmony(TM) Prenatal Test, is a molecular diagnostics company committed to providing non-invasive, highly accurate and affordable prenatal tests for all pregnant women in an effort to promote and improve maternal and fetal health.

Led by an experienced team of medical doctors and scientists, the company has developed cutting-edge technology to perform a directed analysis of cell-free DNA in blood. The flagship product – the Harmony Prenatal Test – is a simple blood test that provides pregnant women with early, personalized and accurate information on the risk of their baby having a common genetic condition, such as Down syndrome. The Harmony Prenatal Test empowers women to achieve their individual reproductive goals and minimizes the need for expectant mothers to undergo unnecessary invasive procedures, such as amniocentesis.

San Jose, US
171 (est)-5%

Key People at Ariosa Diagnostics

John Stuelpnagel

John Stuelpnagel

Executive Chairman
Ken Song

Ken Song


Ariosa Diagnostics Locations

San Jose, US

Ariosa Diagnostics Metrics

Ariosa Diagnostics Summary

Total Funding

$67.5 M

Latest funding size

$52.7 M

Time since last funding

almost 5 years


Ariosa Diagnostics Company Life